Peahen Gandhi, MD
Urogynecology and Reconstructive Pelvic Surgery · Alpharetta, GANPI 1033314422
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 32.9% of the total. Reporting peaked in 2021 at $712 and has fallen 86.7% since, to $95 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in GA, where the typical reported total is $3,861.
Across 96 payments — averaging $23.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$734
- Nuwellis, Inc.$193
- Astellas Pharma US Inc$159
- Baxter Healthcare$135
- Medtronic$129
- Boston Scientific$114
- plus $768 from 23 others
What the payments were for
- Food & beverage$2,20899%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $734 |
| Nuwellis, Inc. | 1 | $193 |
| Astellas Pharma US Inc | 3 | $159 |
| Baxter Healthcare | 2 | $135 |
| Medtronic | 2 | $129 |
| Boston Scientific | 2 | $114 |
| Axonics, Inc. | 2 | $86 |
| Myovant Sciences Inc. | 4 | $81 |
| Bayer | 3 | $62 |
| Caldera Medical, Inc | 1 | $55 |
| Coopersurgical, Inc. | 2 | $44 |
| Mayne Pharma Commercial LLC | 2 | $40 |
| Johnson & Johnson | 2 | $37 |
| Evofem Biosciences, Inc. | 2 | $36 |
| Gynesonics, Inc. | 2 | $35 |
| Exeltis, USA Inc. | 2 | $33 |
| Pfizer | 1 | $27 |
| AMAG Pharmaceuticals, Inc. | 2 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Laborie Medical Technologies Corp. | 1 | $25 |
| Meditrina | 2 | $24 |
| Optumhealth Care Solutions, LLC | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Shield Therapeutics Inc | 1 | $17 |
| Hologic Inc | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,234 in reported general payments places this provider in the 30th percentile of 32 urogynecology and reconstructive pelvic surgery providers in Georgia.
See all urogynecology and reconstructive pelvic surgery providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 13 | $331 |
| Estradiol | 13 | $305 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Alpharetta
- Jana IllstonAlpharetta$4K
- Robert MooreAlpharetta$1K
- Jason BaileyGainesville$369K
- Cheau WilliamsMoultrie$192K
- David LovejoyMacon$85K
- Anne WiskindAtlanta$51K
- Barbara HenleyAugusta$37K
- Ivrose JosephAugusta$17K
- Jennifer LanzerGainesville$16K
- Joseph StubbsSavannah$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.